Prosecution Insights
Last updated: April 19, 2026
Application No. 17/988,095

ETHYLENE-VINYL ALCOHOL COPOLYMER RESIN COMPOSITION, MULTILAYER STRUCTURE, AND PACKAGE

Final Rejection §103
Filed
Nov 16, 2022
Examiner
CAI, WENWEN
Art Unit
1763
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Mitsubishi Chemical Corporation
OA Round
4 (Final)
60%
Grant Probability
Moderate
5-6
OA Rounds
3y 2m
To Grant
80%
With Interview

Examiner Intelligence

Grants 60% of resolved cases
60%
Career Allow Rate
509 granted / 850 resolved
-5.1% vs TC avg
Strong +20% interview lift
Without
With
+19.8%
Interview Lift
resolved cases with interview
Typical timeline
3y 2m
Avg Prosecution
74 currently pending
Career history
924
Total Applications
across all art units

Statute-Specific Performance

§101
0.8%
-39.2% vs TC avg
§103
43.6%
+3.6% vs TC avg
§102
17.4%
-22.6% vs TC avg
§112
27.9%
-12.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 850 resolved cases

Office Action

§103
DETAILED ACTION The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Response to Amendment The amendment of claims 1, 6 are supported by the specification. Any rejections and/or objections made in the previous Office action and not repeated below are hereby withdrawn. The text of those sections of Title 35, U.S. Code not included in this action can be found in a prior Office action. The new grounds of rejection set forth below are necessitated by applicant's amendment filed on 1/5/2026. Thus, the following action is properly made final. Claim Rejections - 35 USC § 103 Claims 1-4 is/are rejected under 35 U.S.C. 103 as being unpatentable over Komuro (US 2020/0172712, equivalent with WO2019083000). Claim 1: Komura teaches a composition comprising an ethylene-vinyl alcohol copolymer, sodium acetate, stearic acid and zinc stearate (example 1). The amount of sodium acetate on a metal basis is 0.017% based on the total amount of EVOH, stearic acid, zinc stearate and sodium acetate, the amount of zinc stearate on a metal basis is 0.0015% based on the total amount of EVOH, stearic acid, zinc stearate and sodium acetate, and the amount of stearic acid is 0.5 wt% based on the total amount of stearic acid and zinc stearate. Detailed calculations for the following values are available upon request. All numbers in the following tables are given in weight percent. EVOH 100 stearic acid 7.28x10-5 on carboxylate basis 7.28x10-5 on compound basis zinc stearate 0.0015 on metal basis 0.013 on stearate basis 0.0145 on compound basis sodium acetate 0.017 on metal basis 0.043 on acetate basis 0.06 on compound basis Komura further teaches where a multilayer structure is to be produced for use as a food package by using the EVOH resin composition, it is preferred to blend a polyamide resin in the EVOH resin composition in order to prevent an EVOH layer from leaching from an edge of the package after hot water treatment of the package [0066]. The amount of polyamide is not greater than 30wt% based on the weight of EVOH [0064]. Therefore, the weight ratio of EVOH/polyamide is 100/0 to 77/23, please note that the amount of polyamide cannot be zero, the value zero in “100/0” should be interpreted as greater than 0. EVOH 77 stearic acid 5.6x10-5 on carboxylate basis 5.6x10-5 on compound basis zinc stearate 0.00115 on metal basis 0.01 on stearate basis 0.011 on compound basis sodium acetate 0.013 on metal basis 0.033 on acetate basis 0.046 on compound basis polyamide 23 When the amount of polyamide is 30wt% based on EVOH wight, the amount of each ingredient listed above is based on the total amount of EVOH, polyamide, stearic acid, zinc stearate and sodium acetate. Because the amount of polyamide is not greater than 30wt% based on the weight of EVOH, the amount of each ingredient is in the range of the value in the first table and the corresponding value in the second table. Amount of zinc stearate on metal basis/amount of sodium acetate on acetate basis = 0.034. Amount of zinc stearate on metal basis/amount of stearic acid on carboxylate basis = 20.6. Komura does not teach the amount of zinc stearate on metal basis/amount of sodium acetate on acetate basis is 0.04-1.5. However, case law holds that a prima facie case of obviousness exists where the claimed ranges and prior art ranges do not overlap but are close enough that one skilled in the art would have expected them to have the same properties. Titanium Metals Corp. of America v. Banner, 778 F.2d 775, 227 USPQ 773 (Fed. Cir. 1985). Komura is silent with respect to the elongational viscosity of the composition. However, the teachings from Komura have rendered obvious the instantly claimed ingredients and amounts thereof. Therefore, it is reasonable that one of ordinary skill in the art would expect the claimed physical properties to naturally arise. Claim 1: Alternatively, Komura teaches a composition comprising an ethylene-vinyl alcohol copolymer, sodium acetate, stearic acid and zinc stearate (example 1). The amount of sodium acetate on a metal basis is 0.017% based on the total amount of EVOH, stearic acid, zinc stearate and sodium acetate, the amount of zinc stearate on a metal basis is 0.0015% based on the total amount of EVOH, stearic acid, zinc stearate and sodium acetate, and the amount of stearic acid is 0.5 wt% based on the total amount of stearic acid and zinc stearate. Detailed calculations for the following values are available upon request. All numbers in the following tables are given in weight percent. EVOH 100 stearic acid 7.28x10-5 on carboxylate basis 7.28x10-5 on compound basis zinc stearate 0.0015 on metal basis 0.013 on stearate basis 0.0145 on compound basis sodium acetate 0.017 on metal basis 0.043 on acetate basis 0.06 on compound basis Komura further teaches where a multilayer structure is to be produced for use as a food package by using the EVOH resin composition, it is preferred to blend a polyamide resin in the EVOH resin composition in order to prevent an EVOH layer from leaching from an edge of the package after hot water treatment of the package [0066]. The amount of polyamide is not greater than 30wt% based on the weight of EVOH [0064]. Therefore, the weight ratio of EVOH/polyamide is 100/0 to 77/23, please note that the amount of polyamide cannot be zero, the value zero in “100/0” should be interpreted as greater than 0. EVOH 77 stearic acid 5.6x10-5 on carboxylate basis 5.6x10-5 on compound basis zinc stearate 0.00115 on metal basis 0.01 on stearate basis 0.011 on compound basis sodium acetate 0.013 on metal basis 0.033 on acetate basis 0.046 on compound basis polyamide 23 When the amount of polyamide is 30wt% based on EVOH wight, the amount of each ingredient listed above is based on the total amount of EVOH, polyamide, stearic acid, zinc stearate and sodium acetate. Because the amount of polyamide is not greater than 30wt% based on the weight of EVOH, the amount of each ingredient is in the range of the value in the first table and the corresponding value in the second table. Amount of zinc stearate on metal basis/amount of sodium acetate on acetate basis = 0.034. Amount of zinc stearate on metal basis/amount of stearic acid on carboxylate basis = 20.6. Komura further teaches the amount of the aliphatic carboxylic acid metal salt (C), i.e. zinc stearate, is 0.0001-0.05wt% on a metal basis based on the total amount of EVOH, stearic acid, zinc stearate and sodium acetate [0048]. The amount of the alkali metal compound (D), sodium acetate, is 0.001-0.1wt% on a metal basis based on the total amount of EVOH, stearic acid, zinc stearate and sodium acetate [0056]. In the example, the amount of zinc stearate on a metal basis is 0.0015%, the amount of sodium acetate on the metal basis is 0.017 wt%, which results in the claimed ratio of 0.034. Therefore, it would have been obvious to one of ordinary skill in the art at the time the invention was made to recognize that the full range of the ratio of amount of zinc stearate on metal basis/amount of sodium acetate on acetate basis would overlap the claimed range. Case law holds that in the case where the claimed ranges “overlap or lie inside ranges disclosed by the prior art” a prima facie case of obviousness exists. In re Wertheim, 541 F.2d 257, 191 USPQ 90 (CCPA 1976); In re Woodruff, 919 F.2d 1575, 16 USPQ2d 1934 (Fed. Cir. 1990). Komura is silent with respect to the elongational viscosity of the composition. However, the teachings from Komura have rendered obvious the instantly claimed ingredients and amounts thereof. Therefore, it is reasonable that one of ordinary skill in the art would expect the claimed physical properties to naturally arise. Claim 2: the amount of zinc stearate on metal basis is greater than 11.5ppm to 15ppm. When considering the full range of the amount of zinc stearate, the amount of zinc stearate on metal basis would overlap the claimed range. Claim 3: the amount of stearic acid on carboxylate basis is greater than 0.56ppm to 0.728ppm. Claim 4: the amount of sodium acetate on acetate basis is greater than 330ppm to 430 ppm. When considering the full range of the amount of sodium acetate, the amount of sodium acetate on acetate basis would overlap the claimed range. Claims 5-6 is/are rejected under 35 U.S.C. 103 as being unpatentable over Komuro (US 2020/0172712) in view of Inoue et al (US 2019/0292359, equivalent with WO2018116765). Claim 5: Komuro teaches the limitation of claim 1, as discussed above. Komuro teaches additional heat stabilizer can be used [0070]. Komuro does not teach a boron compound. However, Inoue teaches EVOH compositions comprises a boron compound as a thermal stabilizer, in an amount of 10-200 ppm on a boron basis based on the weight of the resin composition [0011, 0026, 0110-0114]. Therefore, it would have been obvious to one of ordinary skill in the art at the time the invention was made to include boric acid or its salt in the EVOH composition to further improve thermal stability. Claim 6: amount of zinc stearate on metal basis/amount of boric acid on boron basis = 0.057-1.5, which overlaps the claimed range. Response to Arguments Applicant's arguments filed 1/5/2026 have been fully considered but they are not persuasive. In response to applicant's argument that Komuro is insufficient to anticipate the claims because Komuro fails to disclose an actual example which includes a polyamide resin, it is not persuasive because MPEP does not require an actual example to anticipate the claims. MPEP states “To reject a claim as anticipated by a reference, the disclosure must teach every element required by the claim under its broadest reasonable interpretation.” In this case, Komuro expressly describes a species of a multilayer structure which teaches every element required by the claim. It is not a genus-species situation as stated by the applicant in the Remarks. In response to applicant's argument regarding unexpected results, it is noted that 1) secondary consideration does not apply to 102 rejection, 2) unexpected results should be demonstrated by experimental data, 3) unexpected results should be compared to the closest prior art and be really unexpected, 4) unexpected results should be commensurate in scope with the scope of the claims. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any extension fee pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to WENWEN CAI whose telephone number is (571)270-3590. The examiner can normally be reached on M-F 9am-6pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Joseph Del Sole can be reached on (571)272-1130. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /WENWEN CAI/ Primary Examiner, Art Unit 1763
Read full office action

Prosecution Timeline

Nov 16, 2022
Application Filed
Oct 01, 2025
Non-Final Rejection — §103
Oct 06, 2025
Non-Final Rejection — §103
Oct 09, 2025
Non-Final Rejection — §103
Jan 05, 2026
Response Filed
Jan 26, 2026
Final Rejection — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12600886
RESINS FOR ADHESIVE BONDING OF FABRICS
2y 5m to grant Granted Apr 14, 2026
Patent 12590201
DEGRADATION PROMOTER FOR ALIPHATIC POLYESTER BIODEGRADABLE RESIN, BIODEGRADABLE RESIN COMPOSITION, AND METHOD FOR PROMOTING DEGRADATION OF ALIPHATIC POLYESTER BIODEGRADABLE RESIN
2y 5m to grant Granted Mar 31, 2026
Patent 12559592
BRANCHED AMORPHOUS POLYAMIDE (CO)POLYMERS AND METHODS OF MAKING AND USING SAME
2y 5m to grant Granted Feb 24, 2026
Patent 12552956
PHOTOPOLYMERIZABLE TYPE DENTAL SURFACE COATING COMPOSITION
2y 5m to grant Granted Feb 17, 2026
Patent 12534556
CURABLE COMPOSITION, CURED ARTICLE USING SAME, AND METHOD FOR PRODUCING CURED ARTICLE
2y 5m to grant Granted Jan 27, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

5-6
Expected OA Rounds
60%
Grant Probability
80%
With Interview (+19.8%)
3y 2m
Median Time to Grant
High
PTA Risk
Based on 850 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month